IL33 and glioblastoma: Of this cohort of samples, >50% of samples expressed IL-33 (Fig. 2a, b) with 8/35 BTICs (22.9%) and 8/26 (30.7%) GBM specimens expressing high levels of IL-33 (≥10 Reads Per Kilobase of transcript per Million mapped reads (RPKM)).